Ocrevus 30 mg (Ocrelizumab SOLUTION) 30 MG

Ocrevus 30 mg is an intravenous solution used for managing specific autoimmune conditions. This medication, containing ocrelizumab, is designed to target certain cells in the immune system.

Strength

30 MG

Pack Size

15ML VIAL

Manufacturer / TM Owner

HOFFMANN-LA ROCHE LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Ocrevus 30 mg is primarily used for the treatment of certain autoimmune disorders. It works by affecting the immune system's response, which can help manage symptoms associated with these conditions. People often ask, 'What is Ocrevus used for?' and the answer typically involves its role in modulating immune responses.

Side Effects

Common effects of Ocrevus 30 mg may include infusion-related reactions such as fever, chills, or fatigue. Some individuals might experience mild to moderate side effects, but these can vary widely among users.

Precautions & Warnings

Ocrevus 30 mg should be administered under medical supervision. It is important to discuss any existing health conditions or allergies with a healthcare provider before starting this treatment. Proper handling and storage are crucial to maintain the medication's efficacy.

Avoid Interactions

Ocrevus 30 mg may interact with other medications, particularly those that affect the immune system. It is advisable to inform healthcare providers about all current medications to avoid potential interactions. Alcohol and certain supplements might also influence its effects.

Frequently Asked Questions

Ocrevus 30 mg is used to manage certain autoimmune conditions by modulating the immune system's response.

Ocrevus 30 mg is administered intravenously, typically in a clinical setting under medical supervision.

Common side effects may include infusion-related reactions such as fever, chills, or fatigue.

It is important to discuss all current medications with a healthcare provider to avoid potential interactions.

Ocrevus 30 mg should be stored as per the manufacturer's instructions to maintain its efficacy.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.